•The diagnosis of infant colic was based according to Rome III criteria. All the enrolled children were randomly assigned to receive Chamomilla L., Melissa Officinalis L. and tyndallized L. Acidophilus (H122) (Group A; n=60), L reuteri DSM 17938 (10 8 CFU) (Group B; n = 59) or simethicone (Group C; n=57). Baseline characteristics of the enrolled patients are showed in Table 1. •Treatment was given to subjects for 28 days. Treatment success was assessed at the end of study period. Infants who experienced a decrease in the daily average crying time of 50% from baseline were considered as responders to the treatment. Daily crying, fussing time and sleep duration were recorded in a structured diary, and maternal questionnaires were completed to monitor changes in infant colic symptoms and adverse events.
Results
•Treatment success at 28 days was observed in 57 out of 60 patients (95%) of infants in Group A, while it was seen in 47 out of 54 patients (87%) of Group B and in 38 out of 55 (69.1%) of subjects of Group C (p=0.1 and p=0.0001). Figure 1 shows percentages of responders at different time points.
•Mean daily crying time at 28 days was more significantly reduced in group A (from 207.5 ± 39 min/day to 17 ± 37 min/day) when compared with Group B (from 206.2 ± 37.7 min/day to 35.1 ± 48.2 min/day) and with Group C (from 205.2 ± 32 min/day to 66.8 ± 75.1 min/day) (p=0.006 and p=0.0001 respectively) (Figure 2 ).
•Mean daily fuss time at 28 days was more significantly reduced in group A (from 97.3 ± 60.8 min/day to 27.9 ± 39 min/day) when compared with Group C (from 107.1±70.7 min/day to 58.4± 58.8 min/day) (p=0.05). No significant difference was observed with Group B (from 99.4 ± 58.2 min/day to 33.6 ± 44.6 min/day) (p=0.1). Sleep duration was significantly increased in group A (247±43.9 to 317±48.6) when compared to group C (253±54.6 to 300±48.6) (p=0.05). No significant difference was observed when comparing Group B (265.7±69 to 322±61.4). No adverse events were reported in any group.
Conclusions
•This study suggests that administration of Chamomilla L., Melissa Officinalis L. and tyndallized L. Acidophilus (H122) and L reuteri DSM 17938 are significantly more effective than simethicone in improving colic symptoms.
•A mixture of standardized extract of matricariae Chamomilla L., Melissa Officinalis L. and tyndallized Lactobacillus Acidophilus (H122) seems to be superior to L reuteri DSM 17938 in reducing mean daily crying.
•The use of herbal supplements may represent a new therapeutic strategy in the management of colicky infants. 
